s6y

425 Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Filed
Accession number
0000950135-08-003166

Documents

  1. INVERNESS MEDICAL INNOVATIONS, INC. 425
  2. EX-99.1 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL STATEMENTS EX-99.1

On sec.gov